New drug 'Virafin' to soon support treatment of COVID patients in Lucknow & 2 other UP districts

Within next 2-3 days, the drug shall be provided to one hospital in each of the three districts.

Expanding the range of available resources for the treatment of COVID infected individuals, Zydus Cadila's new drug 'Virafin', will be soon provided at medical centres in Lucknow, Kanpur and Prayagraj in Uttar Pradesh. As per the statement of a government official, this medicine with proven efficiency for COVID treatment, will be given to one hospital in each of these three cities within the next two to three days.

Introduction of a new drug may reap significant benefits

Speaking about this latest development, the Chief Minister asserted that the scientists in the country are working devotedly to find viable alternatives for the cure of COVID-affected individuals. While the crunch in medical facilities is hampering the process of treatments in Uttar Pradesh, it would be interesting to note, if the introduction of this new drug can reap significant benefits. After observing the usage of the drug in the three districts, it is anticipated that the medicine will be further provided in all regions.

UP Government issues new guidelines for providing Remdesivir injections

Ushering in a sigh of relief for severe COVID patients at hospitals in Uttar Pradesh, the Chief Minister has announced that they will be given Remdesivir injections free of cost. In this regard, the CM has instructed officials to ensure that all districts have a sufficient amount of Remdesivir available in their inventories, in accordance with the demand. Orders related to this have been given out by the Department of Health and Family Welfare.

It is to be noted that the private hospitals will have to get this drug from the production companies in the general markets. In case, Remdesivir is not available in private hospitals and it is essential for the survival of any patient, then on the basis of the hospital's prescription, the district magistrate and the Chief Medical Officer (CMO) can provide this life-saving drug for the concerned patient.

It has been mandated that Remdesivir will only be given to the patients receiving treatment at the hospitals after their doctor approves it. Currently, 5,500 individuals are being given this drug on a daily basis in Uttar Pradesh. Remdesivir vials will be provided every day to hospitals having L-2 COVID beds, including government and private centres and medical colleges. Further, each district of Uttar Pradesh will be given 1,800 vials of these injections for an emergency situation.

-With inputs from IANS

Public movement without e-pass permitted for THESE categories in Lucknow & other UP districts!

In an extension of the e-pass order, the state has clarified ambiguities.

In a bid to prevent people from unnecessarily flocking outside amid peak COVID horror of the second wave, the Uttar Pradesh cabinet has issued an e-pass system for public movement across the state. According to this order, the general public, except those involved in essential services, require an authorised electronic pass to validate their travel. However, in an extension of the e-pass order, the state has clarified ambiguities and listed categories of services alongside public movements, that would not require an e-pass.

Keep reading... Show less

Additional COVID-19 curbs imposed in Goa until May 10 in wake of COVID surge

Essential services will continue to operate in Goa without any restrictions.

Goa Government on Tuesday, imposed additional COVID-19 curbs across village panchayats and districts, to keep the coronavirus infection rise in check. The coastal state observed a 4-day lockdown that concluded on May 3, however, strict restrictions were ordained here for another week, till May 10. While the administration had listed the guidelines earlier, on Tuesday, it extended the scope of the prohibitions, to include non-essential services also. As per reports, restaurants too, have been allowed only for home delivery, instead of the earlier permitted operations at 50% capacity.

Keep reading... Show less

Oxygen cylinder blast at Lucknow's Chinhat area stirs city dwellers amid widespread COVID chaos

Technical teams are assessing the situation at the spot and the cause of the blast will be made public soon.

While Lucknow stands shrouded beneath a storm of COVID troubles, an incident at the city's KT Oxygen Filling Station in Chinhat, has raised eyeballs across the city. An oxygen cylinder burst out at 3:30 PM on Wednesday while being reloaded at the facility and chaotic circumstances ensued after that. Taking quick control of the situation, the authorities implemented a relief program to help the individuals affected by the blast and further investigation has been initiated.

Keep reading... Show less

In a first for India, Mumbai's Coastal Road project to be supported by monopile technology!

This is the first time when monopile technology is being used in India.

The construction work of Mumbai's Coastal Road project is going on in full swing, although the city still lies shrouded under the gloom of the raging pandemic. The Brihanmumbai Municipal Corporation (BMC) has also deployed monopile technology for the project, that connects south Mumbai to the western suburbs. Breaking the usual trend of using group pile technology while making any bridge on a sea or river, this is the first time when monopile technology is being used in India.

Keep reading... Show less

COVID cases in Indore exceed beyond ​the 1500-mark on Tuesday for over 3 weeks in a row!

On Tuesday, as many as 1,805 people tested positive for the coronavirus infection in Indore.

The rising scale of COVID-19 infections continues to cast the horrors of the pandemic in Indore, with the addition of 1,805 new cases on Tuesday. Besides adding to the active load, this new surge denotes that the daily spike of the fresh cases in Indore, has surged over the 15,000-mark for over 3 weeks. Meanwhile, the dip in the recovery rate further intensifies the pandemic crisis in the district.

Keep reading... Show less

Subscribe to our newsletter


Most Read